Abbott Laboratories CEO Robert Ford's 2020 pay jumps 72% to $20M

Abbott Laboratories reports 2020 executive compensation

By ExecPay News

Published: March 12, 2021

Abbott Laboratories reported fiscal year 2020 executive compensation information on March 12, 2021.
In 2020, seven executives at Abbott Laboratories received on average a compensation package of $11M, a 9% decrease compared to previous year.
Average pay of disclosed executives at Abbott Laboratories
Robert B. Ford, Chief Executive Officer, received $20M in total, which increased by 72% compared to 2019. 28% of Ford's compensation, or $5.6M, was in option awards. Ford also received $4.2M of change in pension value and nonqualified deferred compensation earnings, $3.7M in non-equity incentive plan, $1.3M in salary, $5.6M in stock awards, as well as $78K in other compensation.
For fiscal year 2020, the median employee pay was $77,594 at Abbott Laboratories. Therefore, the ratio of Robert B. Ford's pay to the median employee pay was 264 to one.
Miles D. White, Chairman, received a compensation package of $20M, which decreased by 29% compared to previous year. 30% of the compensation package, or $6M, was in option awards.
Robert E. Funck, Jr, Chief Financial Officer, earned $9.8M in 2020.
Hubert L. Allen, General Counsel, received $8.5M in 2020, which increases by 13% compared to 2019.
John F. Ginascol, Executive Vice President, Core Diagnostics, earned $6.8M in 2020.
Daniel G. Salvadori, Executive Vice President, Nutritional Products, received $6M in 2020, which decreases by 12% compared to 2019.
Brian B. Yoor, Chief Financial Officer, earned $3.5M in 2020, a 61% decrease compared to previous year.

Related executives

Robert Ford

Abbott Laboratories

Chief Executive Officer

Robert Funck

Abbott Laboratories

Chief Financial Officer

Hubert Allen

Abbott Laboratories

General Counsel

John Ginascol

Abbott Laboratories

Executive Vice President, Core Diagnostics

Daniel Salvadori

Abbott Laboratories

Executive Vice President, Nutritional Products

Miles White

Abbott Laboratories

Chairman

Brian Yoor

Abbott Laboratories

Chief Financial Officer

You may also like

Source: SEC filing on March 12, 2021.